13F filer · CIK 1422849 ↗

Capital World Investors

You are looking at Q4 2025. See the latest, Q2 2026 →

Reported value

$735.30B

+0.4% on the quarter before

Positions

574

47 new · 41 sold out

Top 10

30.7%

of the value

Est. gain

+$8.70B

on stocks held all quarter

Est. return

+1.3%

on those stocks since Q3 2025

Filed

Feb 11, 2026

On SEC EDGAR ↗

Positions as of Dec 31, 2025, from Capital World Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

  • New
  • Added
  • Cut
  • Same
  • Options

The 24 largest positions, 45% of the reported value, each sized by its share, colored by what the fund did with it since Q3 2025. Striped tiles are options.

Broadcom5.8%Microsoft4.2%Meta3.6%Nvidia3.3%
Philip Morris Intl Inc2.9%
Tesla2.6%Alphabet2.3%Micron2.3%Eli Lilly2.2%
Vertex Pharmaceuticals Inc1.6%
Alphabet1.2%Visa Inc.1.2%Netflix1.1%TSMC1.1%Amazon1.1%
Bank America Corp1.1%
Shopify Inc1.0%
Amgen Inc1.0%
Apple1.0%
Unitedhealth Group Inc1.0%
Starbucks Corp1.0%
Cloudflare1.0%
Canadian Nat Res Ltd0.9%
Ge Aerospace0.9%

Largest buys

Since Q3 2025, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Netflix~$7.50BAdded · 1.5% → 1.1%+80,025,890 shares
  2. Union Pac Corp~$2.23BAdded · 0.3% → 0.6%+9,655,306 shares
  3. Johnson & Johnson~$2.01BNew · 0.0% → 0.3%+9,692,884 shares
  4. Apple~$1.92BAdded · 0.7% → 1.0%+7,051,207 shares
  5. Deere & Co~$1.56BAdded · 0.4% → 0.6%+3,358,264 shares
  6. Abbvie Inc~$1.54BAdded · 0.2% → 0.4%+6,736,161 shares
  7. IBM~$1.47BAdded · 0.7% → 0.9%+4,976,756 shares
  8. Brookfield Corp~$1.41BAdded · 0.6% → 0.6%+30,755,354 shares
  9. Amgen Inc~$1.41BAdded · 0.7% → 1.0%+4,302,237 shares
  10. Reddit Inc~$1.29BNew · 0.0% → 0.2%+5,626,017 shares

Largest sells

Since Q3 2025, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Broadcom~$4.27BCut · 6.1% → 5.8%−12,329,760 shares
  2. Linde Plc~$3.85BCut · 0.7% → 0.1%−9,031,735 shares
  3. Motorola Solutions Inc~$3.26BCut · 0.6% → 0.0%−8,507,845 shares
  4. Blackrock Inc~$2.65BCut · 0.6% → 0.1%−2,472,588 shares
  5. Amazon~$2.25BCut · 1.3% → 1.1%−9,761,133 shares
  6. Jpmorgan Chase & Co.~$1.92BCut · 1.0% → 0.8%−5,954,212 shares
  7. Micron~$1.69BCut · 1.5% → 2.3%−5,937,371 shares
  8. Eog Res Inc~$1.50BCut · 0.8% → 0.6%−14,300,375 shares
  9. Fiserv Inc~$1.41BCut · 0.5% → 0.0%−20,936,453 shares
  10. Microsoft~$1.10BCut · 4.7% → 4.2%−2,272,779 shares

Holdings

As of Dec 31, 2025. Changes are in shares against Sep 30, 2025, so a price move alone never reads as a buy or a sale.

Positions, sorted by share of the portfolio
HoldingValue
BroadcomCOM · shares −9.1% · price +4.9%5.8%$42.66B+$2.00B
MicrosoftCOM · shares −3.4% · price −6.6%4.2%$31.18B−$2.21B
MetaCL A · shares +0.8% · price −10.1%3.6%$26.11B−$2.92B
NvidiaCOM · shares −3.1% · price −0.0%3.3%$24.40B−$8.7M
Philip Morris Intl IncCOM · shares +2.8% · price −1.1%2.9%$21.23B−$231.6M
TeslaCOM · shares −3.5% · price +1.1%2.6%$19.11B+$212.9M
AlphabetCAP STK CL A · shares +1.5% · price +28.8%2.3%$16.87B+$3.71B
MicronCOM · shares −9.3% · price +70.6%2.3%$16.63B+$6.88B
Eli LillyCOM · shares +0.4% · price +40.9%2.2%$16.15B+$4.67B
Vertex Pharmaceuticals IncCOM · shares −1.5% · price +15.8%1.6%$11.57B+$1.57B
AlphabetCAP STK CL C · shares +0.8% · price +28.8%1.2%$9.05B+$2.01B
Visa Inc.COM CL A · shares −1.3% · price +2.7%1.2%$8.58B+$228.7M
NetflixCOM · shares +859% · price −92.2%1.1%$8.38B−$10.30B
TSMCSPONSORED ADS · shares −1.2% · price +8.8%1.1%$8.33B+$674.5M
AmazonCOM · shares −22% · price +5.1%1.1%$7.79B+$379.9M
Bank America CorpCOM · shares −2.1% · price +6.6%1.1%$7.77B+$481.4M
Shopify IncCL A SUB VTG SHS · shares −11% · price +8.3%1.0%$7.70B+$591.4M
Amgen IncCOM · shares +23% · price +16.0%1.0%$7.56B+$848.5M
AppleCOM · shares +35% · price +6.8%1.0%$7.47B+$352.3M
Unitedhealth Group IncCOM · shares +3.8% · price −4.4%1.0%$7.46B−$330.4M
Starbucks CorpCOM · shares +9.0% · price −0.5%0.97%$7.14B−$30.3M
CloudflareCL A COM · shares −12% · price −8.1%0.96%$7.06B−$624.9M
Canadian Nat Res LtdCOM · shares −1.7% · price +5.9%0.92%$6.77B+$378.3M
Ge AerospaceCOM NEW · shares −0.9% · price +2.4%0.89%$6.54B+$154.2M
IBMCOM · shares +29% · price +5.0%0.89%$6.52B+$240.0M
Total · 574 positions100%$735.30B+$8.70B
The filing on SEC EDGAR ↗

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q3 2025 to Q4 2025: 519 stocks held throughout, up $8.70B (+1.3%).

  1. Micron+$6.88B+71%
  2. Eli Lilly+$4.67B+41%
  3. Alphabet+$3.71B+29%
  4. Alphabet+$2.01B+29%
  5. Broadcom+$2.00B+5%
  6. Alnylam Pharmaceuticals Inc−$951.0M−13%
  7. Brookfield Corp−$1.55B−33%
  8. Microsoft−$2.21B−7%
  9. Meta−$2.92B−10%
  10. Netflix−$10.30B−92%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 1 split read into the share counts.

Reported value by quarter

The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.

$900.00B$450.00B$0
Q1 2016Q2 2026
Every quarter's filing
Each quarter's 13F filing, newest first
QuarterReported valueFiling
Q2 2026$846.43B+15%SEC ↗
Q1 2026$732.94B−0%SEC ↗
Q4 2025$735.30B+0%SEC ↗
Q3 2025$732.04B+6%SEC ↗
Q2 2025$687.95B+11%SEC ↗
Q1 2025$617.20B−6%SEC ↗
Q4 2024$658.71B+2%SEC ↗
Q3 2024$645.05B+5%SEC ↗
Q2 2024$613.27B+1%SEC ↗
Q1 2024$604.23B+7%SEC ↗
Q4 2023$562.26B+11%SEC ↗
Q3 2023$504.81B−3%SEC ↗
Q2 2023$519.91B+7%SEC ↗
Q1 2023$483.79B+3%SEC ↗
Q4 2022$469.11B+5%SEC ↗
Q3 2022$445.41B−5%SEC ↗
Q2 2022$470.72B−19%SEC ↗
Q1 2022$580.76B−8%SEC ↗
Q4 2021$632.21B+8%SEC ↗
Q3 2021$585.85B−0%SEC ↗
Q2 2021$588.43B+9%SEC ↗
Q1 2021$541.07B+4%SEC ↗
Q4 2020$518.94B+14%SEC ↗
Q3 2020$456.91B+11%SEC ↗
Q2 2020$413.27B+20%SEC ↗
Q1 2020$344.62B−23%SEC ↗
Q4 2019$447.39B+8%SEC ↗
Q3 2019$415.21B−3%SEC ↗
Q2 2019$426.29B+3%SEC ↗
Q1 2019$412.39B+12%SEC ↗
Q4 2018$369.11B−10%SEC ↗
Q3 2018$411.05B−12%SEC ↗
Q2 2018$467.29B+5%SEC ↗
Q1 2018$444.21B−4%SEC ↗
Q4 2017$461.25B+4%SEC ↗
Q3 2017$441.49B+4%SEC ↗
Q2 2017$425.76B+2%SEC ↗
Q1 2017$418.31B+5%SEC ↗
Q4 2016$397.60B+3%SEC ↗
Q3 2016$384.55B+4%SEC ↗
Q2 2016$370.85B+2%SEC ↗
Q1 2016$361.93BSEC ↗

Get the newsletter

The day's AI and market news, in your inbox every weekday.